Prognostic significance of p27KIP1 expression in resected non-small cell lung cancers: Analysis in combination with expressions of p16INK4A, pRB, and p53

Journal of Surgical Oncology

Volumn 81, Issue 4, 2002, Pages 177-184

  Hirabayashi, Hirohisa ^a   Ohta, Mitsunori ^a   Tanaka, Hisaichi ^a   Sakaguchi, Masahiro ^a   Fujii, Yoshitaka ^b   Miyoshi, Shinichiro ^a   Matsuda, Hikaru ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b NAGOYA CITY UNIV MEDICAL SCHOOL   (Japan)

Author keywords

NSCLC; P16; P27; P53; PRB; Prognosis

Indexed keywords

PROTEIN P16; PROTEIN P27; PROTEIN P53; CELL CYCLE PROTEIN; CYCLIN DEPENDENT KINASE INHIBITOR 1B; PROTEIN P16INK4A; RETINOBLASTOMA PROTEIN; TUMOR SUPPRESSOR PROTEIN;

ADULT; AGED; ARTICLE; CANCER STAGING; CANCER SURVIVAL; CELL CYCLE; CLINICAL FEATURE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; SURVIVAL RATE; TREATMENT OUTCOME; TUMOR SUPPRESSOR GENE; ADENOCARCINOMA; BIOSYNTHESIS; LUNG TUMOR; METABOLISM; MIDDLE AGED; PATHOLOGY; SQUAMOUS CELL CARCINOMA;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SQUAMOUS CELL; CELL CYCLE PROTEINS; CYCLIN-DEPENDENT KINASE INHIBITOR P16; CYCLIN-DEPENDENT KINASE INHIBITOR P27; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; RETINOBLASTOMA PROTEIN; TUMOR SUPPRESSOR PROTEIN P53; TUMOR SUPPRESSOR PROTEINS;

EID: 0036891964     PISSN: 00224790     EISSN: None     Source Type: Journal    
DOI: 10.1002/jso.10176     Document Type: Article

References (33)

1. Marshall CJ: Tumor suppressor genes. Cell 1994;64:313-326.
2. Sherr C: Cancer cell cycles. Science 1996;274:1672-1677.
3. Toyoshima H, Hunter T: p27, a novel inhibitor of G1 cyclin-cdk protein kinase activity. Cell 1994;78:67-74.
4. Sakaguchi M, Fujii Y, Hirabayashi H, et al.: Inversely correlated expression of p16 and Rb protein in non-small cell lung cancers: An immunohistochemical study. Int J Cancer 1996;65:442- 445.
5. INK4A expression in resected non-small cell lung tumors. Cancer Res 1996;56:3415-3420.
6. Iggo R, Gatter K, Bartek J, et al.: Increased expression of mutant forms of p53 oncogene in primary lung cancer. Lancet 1990; 335:675-679.
7. Quinlan DC, Davidson AG, Summer CL, et al.: Accumulation of p53 protein correlates with a poor prognosis in human lung cancer. Cancer Res 1992;52:4828-4832.
8. Esposito V, Baldi A, De-Luca A, et al.: Prognostic role of the cyclin-dependent kinase inhibitor p27 in non-small cell lung cancer. Cancer Res 1997;57:3381-3385.
9. INK4A expression in nonsmall cell lung carcinoma. Cancer 1997;80:389-395.
10. Kawabuchi B, Moriyama S, Hironaka M, et al.: p16 inactivation in small sized lung adenocarcinoma: Its association with poor prognosis. Int J Cancer 1999;84:49-53.
11. INK4 and retinoblastoma protein status in non-small cell lung cancer: Potential synergistic effect with altered p53 protein proliferative activity. Cancer Res 1996;56:5557-5562.
12. Chen JT, Chen YC, Chen CY, et al.: Loss of p16 and/or pRb protein expression in NSCLC. An immunohistochemical and prognostic study. Lung Cancer 2001;31:163-170.
13. Xu H, Quinlan DC, Davidson AG, et al.: Altered retinoblastoma protein expression and expression and prognosis in early stage non-small-cell lung cancer. J Natl Cancer Inst 1994;86:695-699.
14. Geradts J, Fong KM, Zimmerman PV, et al.: Correlation of abnormal RB, p16, and p53 expression with 3p loss of heterozygosity, other genetic abnormalities, and clinical features in 103 primary non-small cell lung cancers. Clin Cancer Res 1999;5: 791-800.
15. Lee JS, Yoon A, Kalapurakal SK, et al.: Expression of p53 oncoprotein in non-small-cell lung cancer: A favorable prognostic factor. J Clin Oncol 1995;13:1893-1903.
16. Ishihara S, Minato K, Hoshino H, et al.: The cyclin-dependent kinase inhibitor p27 as a prognostic factor in advanced non-small cell lung cancer: Its immunohistochemical evaluation using biopsy specimens. Lung Cancer 1999;26:187-194.
17. Kip1 in non-small cell lung carcinoma: A prognostic factor independent of Ras. Cancer Res 1999;59: 684-688.
18. Tanaka H, Fujii Y, Hirabayashi H, et al.: Disruption of the RB pathway and cell-proliferative activity in non-small-cell lung cancers. Int J Cancer 1998;79:111-115.
19. KIP1 protein: Prognostic implications in primary breast cancer. Nat Med 1997;3:227-230.
20. Loda M, Cukor B, Tam SW, et al.: Increased proteasome- dependent degradation of the cyclin-dependent kinase inhibitor p27 in aggressive colorectal carcinomas. Nat Med 1997;3:231-234.
21. Jin M, Inoue S, Umemura T, et al.: Cyclin D1, p16 and retino-blastoma gene product expression as a predictor for prognosis in non-small cell lung cancer at stage I and II. Lung Cancer 2001;34:207-218.
22. Takahashi T, Nau MM, Chiba I, et al.: p53: A frequent target for genetic abnormalities in lung cancer. Science 1989;246:491-494.
23. Nishio M, Koshikawa T, Kuronishi T, et al.: Prognostic significance of abnormal p53 accumulation in primary, resected non-small-cell lung cancers. J Clin Oncol 1996;14:497-502.
24. Brambilla E, Brambilla C: p53 and lung cancer. Pathol Biol 1997;45:852-863.
25. Niklifiski J, Nikliñska W, Laudanski J, et al.: Prognostic molecular makers in non-small cell lung cancer. Lung Cancer 2001;34:S53-S58.
26. Mitsudomi T, Hamajima N, Ogawa M, et al.: Prognostic significance of p53 alterations in patients with non-small cell lung cancer: A meta-analysis. Clin Cancer Res 2000;6:4055-4063.
27. Cagini L, Monacelli M, Giustozzi G, et al.: Biological prognostic factors for early stage completely resected non-small cell lung cancer. J Surg Oncol 2000;74:53-60.
28. Pagano M, Tam SW, Theodoras AM, et al.: Role of the ubiquitin-proteasome pathway in regulating abundance of the cyclin-dependent kinase inhibitor p27. Science 1995;269:683-685.
29. Ponce-Castaneda MV, Lee MH, Latres E, et al.: p27: Chromosomal mapping to 12p12-12p13.1 and absence of mutations in human tumors. Cancer Res 1995;55:1211-1214.
30. Kip1 correlates with a shortened survival in non-small cell cancer. Lung Cancer 2001;34:83-90.
31. Shamma A, Doki Y, Tsujinaka T, et al.: Loss of p27 (KIP1) expression predicts poor prognosis in patients with esophageal squamous cell carcinoma. Oncology 2000;58:152-158.
32. Hommura F, Dosaka-Akita H, Mishima T, et al.: Prognostic significance of p27 Kip1 protein and Ki-67 growth fraction in non-small cell cancers. Clin Cancer Res 2000;6:4073-4081.
33. Hayashi H, Ogawa N, Ishiwa N, et al.: High cyclin E and low p27/ Kip1 expressions are potentially poor prognostic factors in lung adenocarinoma patients. Lung Cancer 2001;34:59-65,